The Wellcome Trust has provided Novacta Biosystems, an anti-infective therapeutics company, with a £3.5m award and investment. The deal sees medical research charity Wellcome take a minority stake in the business which previously received £900,000 of funding from the Rainbow Seed Fund and Oxford Technology 4 VCT in 2005.
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Director appointments include Rutland Partners' Matt Hamilton-Allen, who joins the investment team
New vehicle exceeded target by more than USD 300m; aims for up to 20% exposure to European debt
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets